that one's like riding a wild stallion (.08 spread on 3.5M shares?) - SORL moves up $5.08 + 6% CARA trying to get over $13...
fav #1 in o&g: APC $48.23 +.43 (Anadarko) TipRanks: "Based on 8 analysts offering 12 month price targets for APC in the last 3 months. The average price target is $58.63 with a high estimate of $73.00 and a low estimate of $37.00." fav #2: RRC: $19.60 +.17 Range Resouces): institutions own 96.17% - hdge fd fav. TipRanks: target: $26.23▲ (33.76% Upside) Based on 12 analysts offering 12 month price targets for RRC in the last 3 months. The average price target is $26.23 with a high estimate of $35.00 and a low estimate of $19.00. 263 holders increased their positions by a total of 35.82 million shares, 188 holders decreased the positions by a total of 27.65 million shares, and 55 holders held their positions. This works out to a net increase in ownership of 8.16 million shares, and suggests that institutions are feeling bullish about the stock.
i like riding wild stallions even though i never have (although, have helped catch a couple wild ones but they were babies & i served to calm them down so they could be roped without getting as beat up ) Like my/YOUR entry price on SORL BUT not sure how it's going or how soon. Watching CARA & her cousin along with GLYC &ABEO etc Thinking about picking up some TXRC for o/n - holding up pretty well & conf call tomorrow but not sure about this one yet either - might be better wait to see what it's doing in pre...
work a lot with animals and sorry meant "TRXC" but posted correctly earlier Insiders still holding at these 2015 levels & CFO Form 4 today - exercised warrants @ $1. & picked up 200K https://www.sec.gov/Archives/edgar/data/876378/000120919117056991/xslF345X03/doc4.xml
Vol off the charts & was SO hard to not buy this b/c could really rocket up (or down lol) tomorrow so might wanna watch pre - conf call @ 8 am
news: BDRBF: $1.88 (ADR) will probably pop in the am: OCTOBER 16, 2017 / 6:31 PM / Airbus to take majority stake in Bombardier C-Series jet program MONTREAL/PARIS (Reuters) - Airbus SE (AIR.PA) said on Monday it would acquire a majority stake in Bombardier Inc’s (BBDb.TO) CSeries program in a deal that the Canadian plane-and-train-maker said would boost sales and position the company strategically against a potentially costly U.S. trade dispute with Boeing Co (BA.N). Airbus Chief Executive Tom Enders said the company has offered to assemble some of the narrowbody jets at its U.S. plant in Alabama for orders by American carriers. The U.S. assembly line would mean the 110 to 130 seat jets would not be subject to possible U.S. anti-subsidy and anti-dumping duties of 300 percent, Bombardier Chief Executive Alain Bellemare said at a press conference. “There is a ton of strategic value in doing this deal,” Bellemare said. Talks for the deal first started in August. Enders said the deal is different from an earlier round of talks in 2015, when Airbus abruptly ended negotiations, Reuters reported then. He said the plane is performing better. “It’s an entirely different situation,” he said. Under the deal, Bombardier will own about 31 percent, while Investissement Québec, the investment arm of the province of Quebec, will hold 19 percent once the deal closes. Under the deal, Bombardier will own about 31 percent, while Investissement Québec, the investment arm of the province of Quebec, will hold 19 percent once the deal closes.
@Neil Allen something must be up with airlines - SAVE up a/h too & will add yours to my watch list for morning. A few i will be watching unless some other play jumps out @ me in pre again >> TRXC - ABEO - PETZ - IMGN (have small starter but not much & silly me for even thinking $5.50 was a possibility - $6.39 a/h so probably ready to head north now to pay those that paid $6.50 lol)
Playing TRXC today. A few good plays today but wanted the above yesterday so it's the play today as long as it keeps on moving up but a few others under $5 that some might wanna keep on radar EYES (old play) news >> Second Sight Receives Approval from Bundesinstitut für Arzneimittel und Medizinprodukte in Germany to Begin Study to Implant and Evaluate Argus II in Better-Sighted Retinitis Pigmentosa Patients - https://finance.yahoo.com/news/second-sight-receives-approval-bundesinstitut-110000634.html NEOT news (over $1 right now) >> Neothetics, Inc. and Evofem Biosciences, Inc. Announce Merger Agreement to Create Women’s Health Company - https://finance.yahoo.com/news/neothetics-inc-evofem-biosciences-inc-120000931.html RCON still trying but not able to break $2.50 but started off good but not as good as yesterday
this is almost as bad as HMNY - stomach all tied up & sold @ $4.35 - RSI up there on 1 minute & needs to breathe >> i think
@Neil Allen Are you kidding me- ima riding a wild stallion & you want me to check out a good working horse
